GlassScriptPhysician profile
Rashad G Choudry
NPI 1407077316
$3,308.62
in general payments reported to CMS, 2019-2025
17 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $556 · 2021: $412 · 2022: $946 · 2023: $379 · 2024: $666 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,246.81 | 2021-2024 | Endurant Iis |
| Boston Scientific Corporation | $435.77 | 2020-2024 | Eluvia, Ranger, Angiojet Ultra 5000a |
| Shockwave Medical, INC | $298.11 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $181.74 | 2019-2020 | |
| Organogenesis INC. | $177.95 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $164.31 | 2019 | |
| Penumbra, INC. | $153.32 | 2022 | |
| Endologix LLC | $148.35 | 2022 | |
| Cardiovascular Systems INC. | $142.05 | 2020 | |
| Smith+Nephew, INC. | $101.46 | 2021-2024 | Collagenase Santyl |
| Liquidia Technologies, INC. | $98.76 | 2025 | Yutrepia |
| Misonix INC | $79.72 | 2020 | |
| Philips North America LLC | $17.00 | 2024 | (Az7) Lasers |
| Novo Nordisk INC | $16.88 | 2023 | Ozempic, Rybelsus |
| Mimedx Group, INC. | $16.52 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $15.80 | 2025 | Treprostinil |
| Merck Sharp & Dohme LLC | $14.07 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashad Choudry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.